NEWS DETAIL

  • Source : Press Release
  • Date : 2021-12-17
  • Companies : Roche

Chugai Obtained Highest A-Rating by CDP in Two Categories and SBT Validation for Greenhouse Gas Reduction Target

TOKYO, December 17, 2021 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that the company was awarded the highest rating by a global environmental non-profit CDP, being placed on CDP's A-List in the two categories of climate change and water security. Chugai also announced that the Science Based Target (SBT) initiative validated the greenhouse gas reduction targets in Chugai's Mid-term Environmental Goals 2030, which demonstrate that the targets are consistent with the Paris Agreement goals.

CDP is a non-governmental organization (NGO) in the United Kingdom that was inaugurated in 2000. By sending out questionnaires to major companies around the world and encouraging information disclosure on their efforts to address environmental issues and evaluating them, CDP aims to enhance engagement in environmental issues worldwide. Chugai had started to participate in the reporting in 2012 and was rated 'A‐' and 'B' for climate change and water security respectively in 2020. In 2020, Chugai expressed its endorsement with the recommendations of TCFD (Climate-Related Financial Disclosure Task Force) and identified material issues to establish new science-based medium-term environmental targets. Chugai believes that these continuous efforts and the company's information disclosure led to the results this year.

The SBT initiative is a partnership between four organizations: CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF). It covers not only the direct emissions by the reporting company itself, but also the supply chain emissions from all types of emissions related to business activities. The greenhouse gas reduction targets validated this time are to reduce the total emissions of Scope 1 and Scope 2 by 60% by 2030 and reduce Scope 3 emissions by 30%, both compared to 2019*. As a longer-term goal, Chugai aims to achieve zero Scope 1 and Scope 2 emissions by 2050.

*Scope1: Direct greenhouse gas emissions by the reporting company itself. (e.g. fuel combustion, industrial process). Scope2: Indirect emissions from the use of electricity, heat, or steam supplied by others. Scope3: Indirect emissions other than Scope 1 and Scope 2 (Emissions by others related to the company's activities)

In the growth strategy TOP I 2030, Chugai sets a "role model for the world" as one of three visions as a top innovator in 2030, aiming to become a leader in resolving social issues by pursuing ESG initiatives through business activities. We will continue pursuing environmental measures in all aspects of our business activities to achieve sustainable growth together with the society.

Reference

Chugai's Sustainability: https://www.chugai-pharm.co.jp/english/sustainability/index.html
Mid-term Environmental Goals 2030:
https://www.chugai-pharm.co.jp/english/sustainability/environment/action.html
[PDF 369KB]

Contact:

For Media
Chugai Pharmaceutical Co., Ltd.
Media Relations Group, Corporate Communications Dept.,
Tomoko Shimizu
Tel: +81-3-3273-0881
E-mail: [email protected]
For Investors
Chugai Pharmaceutical Co., Ltd.
Investor Relations Group, Corporate Communications Dept.,
Takayuki Sakurai
Tel: +81-3-3273-0554
E-mail: [email protected]